Table 2 Chemotherapy regimens, number of cycles and patients’ response to first-line chemotherapy
Regimens of first-line chemotherapy | Overall | MTB or MK infection | |
|---|---|---|---|
|  |  | (+) | (–) |
|  | N = 30 | N = 7 | N = 23 |
Intensive regimens | 26 | 6 | 20 |
 FOLFOX | 8 | 2 | 6 |
 FOLFOX + Bmab | 6 | 1 | 5 |
 FOLFIRI | 6 | 1 | 5 |
 FOLFOX + Pmab/Cmab | 2 | 2 | 0 |
 FOLFIRI + Pmab/Cmab | 2 | 0 | 2 |
 FOLFIRI + Bmab | 1 | 0 | 1 |
 XELOX | 1 | 0 | 1 |
Non-intensive regimens | 4 | 1 | 3 |
 UFT/LV | 1 | 1 | 0 |
 S-1 | 2 | 0 | 2 |
 Capecitabine | 1 | 0 | 1 |
Response rate (%) | 40.0 | 28.6 | 43.5 |
 CR | 1 | 1 | 0 |
 PR | 11 | 1 | 10 |
 SD | 10 | 2 | 8 |
 PD | 7 | 3 | 4 |
 NE | 1 | 0 | 1 |